Location: New York, NY
CIK: 0001224962 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $6.662B (99.8% shares, 0.2% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ASND | ASCENDIS PHARMA A/S | 1,163,721 | $310M | 4.7% | — | — | ORD SHS | K08588103 |
| KARD | KARDIGAN INC | 8,200,662 | $196M | 2.9% | — | — | COM | 485925101 |
| AVLN | AVALYN PHARMACEUTICALS INC | 2,675,296 | $88.07M | 1.3% | — | — | COM SHS | 05348Y105 |
| BIIB | BIOGEN INC | 276,173 | $59.67M | 0.9% | — | — | COM | 09062X103 |
| UNH | UNITEDHEALTH GROUP INC | 116,806 | $48.55M | 0.7% | — | — | COM | 91324P102 |
| XBI | SPDR SERIES TRUST | 300,000 | $47.48M | 0.7% | — | — | PUT | 78464A870 |
| CRL | CHARLES RIV LABS INTL INC | 140,000 | $31.75M | 0.5% | — | — | COM | 159864107 |
| EYPT | EYEPOINT INC | 2,000,000 | $28.6M | 0.4% | — | — | PUT | 30233G209 |
| DHR | DANAHER CORP DEL | 130,000 | $24.76M | 0.4% | — | — | COM | 235851102 |
| CAPR | CAPRICOR THERAPEUTICS INC | 1,000,000 | $24.08M | 0.4% | — | — | CALL | 14070B309 |
| SLS | SELLAS LIFE SCIENCES GROUP I | 1,500,000 | $22.14M | 0.3% | — | — | PUT | 81642T209 |
| ANL | ADLAI NORTYE LTD | 1,793,190 | $20.62M | 0.3% | — | — | SPONSORED ADS | 00704R109 |
| NVCT | NUVECTIS PHARMA INC | 1,000,000 | $18.39M | 0.3% | — | — | COM | 67080T108 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 500,000 | $16.95M | 0.3% | — | — | PUT | N62509109 |
| MIRM | MIRUM PHARMACEUTICALS INC | 115,391 | $13.51M | 0.2% | — | — | COM | 604749101 |
| CAPR | CAPRICOR THERAPEUTICS INC | 500,000 | $12.04M | 0.2% | — | — | PUT | 14070B309 |
| OSCR | OSCAR HEALTH INC | 400,000 | $11.41M | 0.2% | — | — | CL A | 687793109 |
| SPTX | SEAPORT THERAPEUTICS INC | 500,000 | $10.86M | 0.2% | — | — | COMMON STOCK | 81221K108 |
| BSX | BOSTON SCIENTIFIC CORP | 250,000 | $10.67M | 0.2% | — | — | COM | 101137107 |
| NTRA | NATERA INC | 34,689 | $9.416M | 0.1% | — | — | COM | 632307104 |
| ENGN | ENGENE THERAPEUTICS INC | 4,822,169 | $8.342M | 0.1% | — | — | COM | 29286X101 |
| RACC | RESEARCH ALLIANCE CORP III | 750,000 | $8.025M | 0.1% | — | — | ORD SHS CL A | G75226103 |
| CGEM | CULLINAN THERAPEUTICS INC | 426,478 | $7.766M | 0.1% | — | — | COM | 230031106 |
| QURE | UNIQURE NV | 168,000 | $7.738M | 0.1% | — | — | SHS | N90064101 |
| MOBI | MOBIA MED INC | 523,654 | $7.017M | 0.1% | — | — | COMMON STOCK | 60705V103 |
| OTLK | OUTLOOK THERAPEUTICS INC | 3,139,216 | $4.991M | 0.1% | — | — | COM | 69012T305 |
| XERS | XERIS BIOPHARMA HOLDINGS INC | 467,013 | $3.699M | 0.1% | — | — | COM | 98422E103 |
| BDSX | BIODESIX INC | 108,694 | $2.451M | 0.0% | — | — | COM | 09075X207 |
| KPRX | KIORA PHARMACEUTICALS INC | 438,471 | $1.153M | 0.0% | — | — | COM | 49721T507 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SYRE | SPYRE THERAPEUTICS INC | 4,319,496 (+14.2%) | $383M (+101.0%) | 5.8% | — | — | COM NEW | 00773J202 |
| RLAY | RELAY THERAPEUTICS INC | 14,106,187 (+44.7%) | $264M (+172.0%) | 4.0% | — | — | COM | 75943R102 |
| TNGX | TANGO THERAPEUTICS INC | 3,377,000 (+317.9%) | $106M (+524.4%) | 1.6% | — | — | COM | 87583X109 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 2,586,295 (+9.0%) | $287M (+39.1%) | 4.3% | — | — | COM | 76243J105 |
| RVMD | REVOLUTION MEDICINES INC | 527,600 (+104.0%) | $98.81M (+292.9%) | 1.5% | — | — | COM | 76155X100 |
| MGTX | MEIRAGTX HLDGS PLC | 10,786,658 (+4.5%) | $146M (+63.2%) | 2.2% | — | — | COM | G59665102 |
| NRIX | NURIX THERAPEUTICS INC | 4,320,422 (+16.4%) | $105M (+82.2%) | 1.6% | — | — | COM | 67080M103 |
| CORT | CORCEPT THERAPEUTICS INC | 398,385 (+696.8%) | $34.64M (+1618.7%) | 0.5% | — | — | COM | 218352102 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 10,308,888 (+38.7%) | $103M (+45.7%) | 1.5% | — | — | COM | 09058V103 |
| STRO | SUTRO BIOPHARMA INC | 1,304,846 (+82.4%) | $43.32M (+143.1%) | 0.7% | — | — | COM SHS | 869367201 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | 1,217,325 (+698.2%) | $26.11M (+1133.6%) | 0.4% | — | — | COM | 00650F109 |
| CELC | CELCUITY INC | 3,197,200 (+2.2%) | $334M (-6.3%) | 5.0% | — | — | COM | 15102K100 |
| ZYME | ZYMEWORKS INC | 4,182,953 (+19.2%) | $109M (+24.4%) | 1.6% | — | — | COM | 98985Y108 |
| AORT | ARTIVION INC | 1,737,290 (+6.1%) | $39.04M (-34.9%) | 0.6% | — | — | COM | 228903100 |
| IRTC | IRHYTHM HOLDINGS INC | 223,766 (+113.1%) | $26.62M (+114.7%) | 0.4% | — | — | COM | 450056106 |
| SION | SIONNA THERAPEUTICS INC | 905,000 (+37.4%) | $39.81M (+50.8%) | 0.6% | — | — | COM | 829401108 |
| EOLS | EVOLUS INC | 2,459,285 (+91.1%) | $17.07M (+222.7%) | 0.3% | — | — | COM | 30052C107 |
| RAPP | RAPPORT THERAPEUTICS INC | 773,342 (+14.8%) | $32.23M (+52.8%) | 0.5% | — | — | COM | 75383L102 |
| XFOR | X4 PHARMACEUTICALS INC | 7,933,491 (+17.7%) | $37.05M (+33.1%) | 0.6% | — | — | COM NEW | 98420X202 |
| CTMX | CYTOMX THERAPEUTICS INC. | 10,439,185 (+3.4%) | $39.15M (-17.5%) | 0.6% | — | — | COM | 23284F105 |
| IONS | IONIS PHARMACEUTICALS INC | 566,000 (+12.3%) | $44.88M (+18.6%) | 0.7% | — | — | COM | 462222100 |
| DBVT | DBV TECHNOLOGIES S A | 1,653,350 (+71.4%) | $27.11M (+34.6%) | 0.4% | — | — | SPONSORED ADS | 23306J309 |
| SRZN | SURROZEN INC | 503,985 (+119.7%) | $13.08M (+95.7%) | 0.2% | — | — | COM NEW | 86889P208 |
| CRVS | CORVUS PHARMACEUTICALS INC | 2,667,441 (+16.4%) | $39.85M (+18.8%) | 0.6% | — | — | COM | 221015100 |
| AVTX | AVALO THERAPEUTICS INC | 219,813 (+57.4%) | $4.062M (+94.8%) | 0.1% | — | — | COM NEW | 05338F306 |
| OCS | OCULIS HOLDING AG | 808,827 (+63.8%) | $11.22M (-14.6%) | 0.2% | — | — | ORDINARY SHARES | H5870P102 |
| TENX | TENAX THERAPEUTICS INC | 1,700,000 (+17.4%) | $24.73M (+6.8%) | 0.4% | — | — | COM NEW | 88032L605 |
| SABS | SAB BIOTHERAPEUTICS INC | 6,627,501 (+3.0%) | $25.85M (+4.9%) | 0.4% | — | — | COM NEW | 78397T202 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ASND | ASCENDIS PHARMA A/S | 1,531,421 | $350M | 5.3% | — | — | — | 04351P101 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 5,258,903 | $209M | 3.1% | — | — | — | 152309100 |
| ENGN | ENGENE HOLDINGS INC | 5,827,506 | $39.69M | 0.6% | — | — | — | 29286M105 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 1,755,799 | $37.64M | 0.6% | — | — | — | 23954D109 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 377,544 | $27.55M | 0.4% | — | — | — | 10919W405 |
| BLTE | BELITE BIO INC | 151,979 | $24.23M | 0.4% | — | — | — | 07782B104 |
| EVMN | EVOMMUNE INC | 448,350 | $10.31M | 0.2% | — | — | — | 30054Y107 |
| NMRA | NEUMORA THERAPEUTICS INC. | 5,104,097 | $9.953M | 0.1% | — | — | — | 640979100 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 65,050 | $8.57M | 0.1% | — | — | — | 64125C109 |
| IRD | OPUS GENETICS INC | 1,835,842 | $8.353M | 0.1% | — | — | — | 67577R102 |
| OCUL | OCULAR THERAPEUTIX INC | 500,000 | $4.235M | 0.1% | — | — | CALL | 67576A100 |
| IKT | INHIBIKASE THERAPEUTICS INC | 2,315,000 | $3.889M | 0.1% | — | — | — | 45719W205 |
| APLS | APELLIS PHARMACEUTICALS INC | 80,956 | $3.257M | 0.0% | — | — | — | 03753U106 |
| PTN | PALATIN TECHNOLOGIES INC | 61,945 | $1.079M | 0.0% | — | — | — | 696077601 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TVTX | TRAVERE THERAPEUTICS INC | 3,752,574 (-9.4%) | $213M (+73.2%) | 3.2% | — | — | COM | 89422G107 |
| ORKA | ORUKA THERAPEUTICS INC | 1,345,063 (-3.6%) | $128M (+87.0%) | 1.9% | — | — | COM | 687604108 |
| ROIV | ROIVANT SCIENCES LTD | 8,085,461 (-2.4%) | $286M (+24.7%) | 4.3% | — | — | SHS | G76279101 |
| APGE | APOGEE THERAPEUTICS INC | 1,308,113 (-15.1%) | $174M (+33.9%) | 2.6% | — | — | COM | 03770N101 |
| EWTX | EDGEWISE THERAPEUTICS INC | 4,373,974 (-1.1%) | $178M (+27.5%) | 2.7% | — | — | COM | 28036F105 |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | 11,634,211 (-7.6%) | $21.76M (-55.5%) | 0.3% | — | — | COM | 63909J108 |
| ABVX | ABIVAX SA | 74,000 (-77.5%) | $9.861M (-73.1%) | 0.1% | — | — | SPONSORED ADS | 00370M103 |
| INBX | INHIBRX BIOSCIENCES INC | 1,297,763 (-10.0%) | $123M (+26.8%) | 1.8% | — | — | COM | 45720N103 |
| DYN | DYNE THERAPEUTICS INC | 2,689,235 (-42.4%) | $59.73M (-29.4%) | 0.9% | — | — | COM | 26818M108 |
| GH | GUARDANT HEALTH INC | 41,327 (-86.2%) | $6.2M (-77.6%) | 0.1% | — | — | COM | 40131M109 |
| ISRG | INTUITIVE SURGICAL INC | 51,884 (-39.3%) | $20.63M (-47.6%) | 0.3% | — | — | COM NEW | 46120E602 |
| IMVT | IMMUNOVANT INC | 1,357,383 (-15.0%) | $52.3M (+31.8%) | 0.8% | — | — | COM | 45258J102 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 581,980 (-50.3%) | $10.69M (-53.3%) | 0.2% | — | — | COM | 92790C104 |
| AXGN | AXOGEN INC | 247,312 (-64.5%) | $11.42M (-50.6%) | 0.2% | — | — | COM | 05463X106 |
| IVVD | INVIVYD INC | 18,490,636 (-11.4%) | $16.13M (-40.5%) | 0.2% | — | — | COM | 00534A102 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 981,879 (-20.2%) | $120M (-7.2%) | 1.8% | — | — | COM | 74366E102 |
| BBNX | BETA BIONICS INC | 832,944 (-1.2%) | $13.05M (+54.5%) | 0.2% | — | — | COM | 08659B102 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 532,000 (-42.5%) | $5.772M (-43.8%) | 0.1% | — | — | COM | 71722W107 |
| AXSM | AXSOME THERAPEUTICS INC. | 118,450 (-21.0%) | $28.99M (+14.4%) | 0.4% | — | — | COM | 05464T104 |
| TWST | TWIST BIOSCIENCE CORP | 36,812 (-75.5%) | $3.787M (-46.9%) | 0.1% | — | — | COM | 90184D100 |
| ADMA | ADMA BIOLOGICS INC | 113,765 (-75.7%) | $952K (-77.4%) | 0.0% | — | — | COM | 000899104 |
| BLLN | BILLIONTOONE INC | 86,812 (-5.4%) | $10.42M (+43.7%) | 0.2% | — | — | CL A | 090168105 |
| ANRO | ALTO NEUROSCIENCE INC | 1,609,893 (-19.9%) | $42.49M (-6.0%) | 0.6% | — | — | COM SHS | 02157Q109 |
| PALI | PALISADE BIO INC | 8,425,065 (-5.6%) | $17.61M (+12.7%) | 0.3% | — | — | COM | 696389402 |
| RGEN | REPLIGEN CORP | 248,212 (-11.5%) | $33.87M (+2.5%) | 0.5% | — | — | COM | 759916109 |
| CPIX | CUMBERLAND PHARMACEUTICALS I | 96,982 (-50.8%) | $628K (-1.8%) | 0.0% | — | — | COM | 230770109 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AMLX | AMYLYX PHARMACEUTICALS INC | 8,334,882 | $150M | 2.2% | — | — | COM | 03237H101 |
| NUVL | NUVALENT INC | 1,580,505 | $195M | 2.9% | — | — | COM | 670703107 |
| SLDB | SOLID BIOSCIENCES INC | 11,906,646 | $119M | 1.8% | — | — | COM NEW | 83422E204 |
| PRAX | PRAXIS PRECISION MEDICINES I | 2,035,986 | $682M | 10.2% | — | — | COM NEW | 74006W207 |
| MRNA | MODERNA INC | 1,000,000 | $70.03M | 1.1% | — | — | PUT | 60770K107 |
| AVR | ANTERIS TECHNOLOGIES GLOBAL | 3,425,476 | $33.74M | 0.5% | — | — | COM | 03675P102 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 170,000 | $40.96M | 0.6% | — | — | SHS USD | G50871105 |
| OMDA | OMADA HEALTH INC | 786,330 | $17.26M | 0.3% | — | — | COM | 68170A108 |
| ADGM | ADAGIO MED HLDGS INC | 9,876,586 | $6.44M | 0.1% | — | — | COM | 00534B100 |
| CTNM | CONTINEUM THERAPEUTICS INC | 1,255,592 | $20.58M | 0.3% | — | — | CL A | 21217B100 |
| IMTX | IMMATICS N.V | 10,383,456 | $105M | 1.6% | — | — | SHS | N44445109 |
| LONA | LEONABIO INC | 1,859,322 | $17.09M | 0.3% | — | — | COM | 04746L203 |
| RVMDW | REVOLUTION MEDICINES INC | 250,000 | $2.345M | 0.0% | — | — | *W EXP 12/17/202 | 76155X118 |
| EDSA | EDESA BIOTECH INC | 563,239 | $4.579M | 0.1% | — | — | COM NEW | 27966L306 |
| AGMB | AGOMAB THERAPEUTICS NV | 600,000 | $7.788M | 0.1% | — | — | SPONSORED ADS | 00860C102 |
| — | CELCUITY INC | 6,500,000 | $14.63M | 0.2% | — | — | NOTE 2.750% 8/0 | 15102KAA8 |
| OM | OUTSET MED INC | 833,333 | $3.6M | 0.1% | — | — | COM NEW | 690145206 |
| OBIO | ORCHESTRA BIOMED HLDGS INC | 5,037,906 | $21.74M | 0.3% | — | — | COM | 68572M106 |
| CNTB | CONNECT BIOPHARMA HLDGS LTD | 792,696 | $1.887M | 0.0% | — | — | SHS | G23549101 |
| XGN | EXAGEN INC | 114,893 | $534K | 0.0% | — | — | COM | 30068X103 |
| MDLN | MEDLINE INC | 28,000 | $1.104M | 0.0% | — | — | COM CL A | 58507V107 |
| GLTO | DAMORA THERAPEUTICS INC | 1,223,000 | $31.81M | 0.5% | — | — | COM NEW | 36322Q206 |
| CBIO | CRESCENT BIOPHARMA INC. | 206,942 | $3.725M | 0.1% | — | — | COM | G2545C104 |
| COGT | COGENT BIOSCIENCES INC | 121,082 | $4.686M | 0.1% | — | — | COM | 19240Q201 |
| ENSC | ENSYSCE BIOSCIENCES INC | 86,666 | $25,133 | 0.0% | — | — | COM NEW | 293602504 |
| SRZNW | SURROZEN INC | 166,666 | $2,750 | 0.0% | — | — | *W EXP 08/01/203 | 86889P117 |